Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 608-818-5 | CAS number: 32997-86-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-05-21 to 2018-06-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- 2002
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- sodium 2-chloroprop-2-enoate
- EC Number:
- 608-818-5
- Cas Number:
- 32997-86-7
- Molecular formula:
- C3H2ClO2.Na
- IUPAC Name:
- sodium 2-chloroprop-2-enoate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: in house bred
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 to 12 weeks
- Weight at study initiation: 160 - 180 g
- Housing: max. 3 animals per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3 °C
- Humidity: 30 - 70 %
- Air changes: 12 to 15 per hr
- Photoperiod: 12 / 12 hrs dark / hrs light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 mg/mL
- Amount of vehicle: 10 mL/kg bw
- Justification for choice of vehicle: water is the recommended vehicle by the guideline
CLASS METHOD
- Rationale for the selection of the starting dose: no information are available about the acute oral toxicity of the test item. Due to precautionary reasons it is classified as acutely toxic cat 4 according to CLP. - Doses:
- 300 mg/kg bw
- No. of animals per sex per dose:
- 3 females in the first run
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All the animals were observed for clinical signs of toxicity and mortality at 30 to 40 min, 1 hr (±10 min), 2 hrs (±10 min), 3 hrs (±10 min) and 4 hrs (±10 min) post dosing on Day 1 and at least once daily thereafter for clinical signs of toxicity throughout the experimental period. Individual animal body weight was recorded at receipt, on day 1 before test item administration and on day 8 and 15 during the observation period.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All the three animals dosed with 2000 mg/kg bw/d were found dead by day 2 observation. No mortality was observed at 300 mg/kg bw/d.
- Clinical signs:
- In Step-I and Step-I confirmation:
The animals were dosed with 300 mg/kg body weight. No clinical signs of toxicity and mortality were observed.
In Step-II, the animals were dosed with 2000 mg/kg body weight. No clinical signs were observed at 30 to 40 minutes. At 1st and 2nd hour clinical signs like lethargy were seen, 3rd hour lethargy and soft stool and at 4th hour recumbency was observed. All the three animals were found dead by day 2 observation. - Body weight:
- No changes were observed in body weight and percent change in body weight with respect to day 1 at 300 mg/kg bw. However, decrease in body weight was observed in dead animals of the 2000 mg/kg bw dose group.
- Gross pathology:
- No gross pathological changes were observed in any of the animals dosed at 300 mg/kg and 2000 mg/kg body weight.
- Other findings:
- - Organ weights: not examined
- Histopathology: not examined
Any other information on results incl. tables
Table 1 Individual animal data on clinical signs of toxicity and mortality
Study Steps & Dose (mg/kg body weight) |
Animal No. |
Sex |
Clinical Signs of Toxicity and Mortality on Day 1 |
Clinical Signs of Toxicity and Mortality on Day |
|||||||||||||||||
30 to 40 min |
1 hr (±10 min) |
2hrs (±10 min) |
3hrs (±10 min) |
4hrs (±10 min) |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
|||
Step-I & 300 |
Rc9524 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
Rc9525 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
|
Rc9526 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
|
Step-I Confirmation & 300 |
Rc9527 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
Rc9528 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
|
Rc9529 |
F |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
N |
|
Step-II & 2000 |
Rc9530 |
F |
N |
1 |
1 |
1, 29 |
42 |
All the three animals were found dead by day 2 observation |
|||||||||||||
Rc9531 |
F |
N |
1 |
1 |
1, 29 |
42 |
|||||||||||||||
Rc9532 |
F |
N |
1 |
1 |
1, 29 |
42 |
N: Normal; F: Female; min/mins: minutes; hr/hrs: Hour/Hours, 1: Lethargy; 29: Soft stool; 42: Recumbency
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Based on the results of this study it is concluded that the LD50 of the test item is 300 < LD50 < 2000 mg/kg bw when administered as a single dose by oral gavage to female Sprague Dawley rats according to OECD 423.
- Executive summary:
The test item was evaluated for acute oral toxicity in Sprague Dawley rats as per OECD Guideline No. 423. A starting dose of 300 mg/kg body weight was selected as there was no available information on the LD50 of the test item.
A total of 9 females (3 females each per Step-I, Step-I confirmation and Step-II) were used. All the animals of Step-I and Step-I confirmation were administered with 300 mg/kg body weight of the test item and Step II were administered with 2000 mg/kg body weight of the test item by oral route (gavage).
All the animals were observed for clinical signs of toxicity and mortality at 30 to 40 min, 1 hr (±10 mins), 2 hrs (±10 mins), 3 hrs (±10 mins) and 4 hrs (±10 mins) post dosing on day 1 and once daily thereafter for clinical signs of toxicity and twice daily for mortality during the 14 days observation period. Body weight was recorded on day 1 before test item administration and on day 8 and 15 during the observation period. At the end of observation period, all the surviving animals were sacrificed under carbon dioxide anaesthesia, subjected to necropsy and gross pathological examination.
In Step-I and Step-I confirmation, the animals dosed with 300 mg/kg body weight did not reveal any clinical signs of toxicity or mortality.
In Step-II, the animals dosed with 2000 mg/kg body weight revealed clinical signs like lethargy, soft faeces and recumbency. All the animals were found dead by day 2 observation. No changes were observed in body weight and percent change in body weight with respect to day 1 at 300 mg/kg bw. All the surviving animals revealed physiologically normal increase in the body weight.No gross pathological changes were observed in any of the animals dosed at 300 mg/kg and 2000 mg/kg body weight.
Based on the findings of this study the acute oral LD50 of the test item in rats is considered to be 300 < LD50 < 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.